182 related articles for article (PubMed ID: 32633004)
1. Ependymoma relapse goes along with a relatively stable epigenome, but a severely altered tumor morphology.
Yang D; Holsten T; Börnigen D; Frank S; Mawrin C; Glatzel M; Schüller U
Brain Pathol; 2021 Jan; 31(1):33-44. PubMed ID: 32633004
[TBL] [Abstract][Full Text] [Related]
2. Molecular characterization of histopathological ependymoma variants.
Neumann JE; Spohn M; Obrecht D; Mynarek M; Thomas C; Hasselblatt M; Dorostkar MM; Wefers AK; Frank S; Monoranu CM; Koch A; Witt H; Kool M; Pajtler KW; Rutkowski S; Glatzel M; Schüller U
Acta Neuropathol; 2020 Feb; 139(2):305-318. PubMed ID: 31679042
[TBL] [Abstract][Full Text] [Related]
3. Epigenomic analysis of Alu repeats in human ependymomas.
Xie H; Wang M; Bonaldo Mde F; Rajaram V; Stellpflug W; Smith C; Arndt K; Goldman S; Tomita T; Soares MB
Proc Natl Acad Sci U S A; 2010 Apr; 107(15):6952-7. PubMed ID: 20351280
[TBL] [Abstract][Full Text] [Related]
4. Emerging insights into the ependymoma epigenome.
Mack SC; Witt H; Wang X; Milde T; Yao Y; Bertrand KC; Korshunov A; Pfister SM; Taylor MD
Brain Pathol; 2013 Mar; 23(2):206-9. PubMed ID: 23432646
[TBL] [Abstract][Full Text] [Related]
5. A retrospective analysis of recurrent pediatric ependymoma reveals extremely poor survival and ineffectiveness of current treatments across central nervous system locations and molecular subgroups.
Ritzmann TA; Rogers HA; Paine SML; Storer LCD; Jacques TS; Chapman RJ; Ellison D; Donson AM; Foreman NK; Grundy RG
Pediatr Blood Cancer; 2020 Sep; 67(9):e28426. PubMed ID: 32614133
[TBL] [Abstract][Full Text] [Related]
6. Molecular heterogeneity and CXorf67 alterations in posterior fossa group A (PFA) ependymomas.
Pajtler KW; Wen J; Sill M; Lin T; Orisme W; Tang B; Hübner JM; Ramaswamy V; Jia S; Dalton JD; Haupfear K; Rogers HA; Punchihewa C; Lee R; Easton J; Wu G; Ritzmann TA; Chapman R; Chavez L; Boop FA; Klimo P; Sabin ND; Ogg R; Mack SC; Freibaum BD; Kim HJ; Witt H; Jones DTW; Vo B; Gajjar A; Pounds S; Onar-Thomas A; Roussel MF; Zhang J; Taylor JP; Merchant TE; Grundy R; Tatevossian RG; Taylor MD; Pfister SM; Korshunov A; Kool M; Ellison DW
Acta Neuropathol; 2018 Aug; 136(2):211-226. PubMed ID: 29909548
[TBL] [Abstract][Full Text] [Related]
7. Predicting which children are at risk for ependymoma relapse.
Sowar K; Straessle J; Donson AM; Handler M; Foreman NK
J Neurooncol; 2006 May; 78(1):41-6. PubMed ID: 16575538
[TBL] [Abstract][Full Text] [Related]
8. MYCN amplification drives an aggressive form of spinal ependymoma.
Ghasemi DR; Sill M; Okonechnikov K; Korshunov A; Yip S; Schutz PW; Scheie D; Kruse A; Harter PN; Kastelan M; Wagner M; Hartmann C; Benzel J; Maass KK; Khasraw M; Sträter R; Thomas C; Paulus W; Kratz CP; Witt H; Kawauchi D; Herold-Mende C; Sahm F; Brandner S; Kool M; Jones DTW; von Deimling A; Pfister SM; Reuss DE; Pajtler KW
Acta Neuropathol; 2019 Dec; 138(6):1075-1089. PubMed ID: 31414211
[TBL] [Abstract][Full Text] [Related]
9. Metabolic Regulation of the Epigenome Drives Lethal Infantile Ependymoma.
Michealraj KA; Kumar SA; Kim LJY; Cavalli FMG; Przelicki D; Wojcik JB; Delaidelli A; Bajic A; Saulnier O; MacLeod G; Vellanki RN; Vladoiu MC; Guilhamon P; Ong W; Lee JJY; Jiang Y; Holgado BL; Rasnitsyn A; Malik AA; Tsai R; Richman CM; Juraschka K; Haapasalo J; Wang EY; De Antonellis P; Suzuki H; Farooq H; Balin P; Kharas K; Van Ommeren R; Sirbu O; Rastan A; Krumholtz SL; Ly M; Ahmadi M; Deblois G; Srikanthan D; Luu B; Loukides J; Wu X; Garzia L; Ramaswamy V; Kanshin E; Sánchez-Osuna M; El-Hamamy I; Coutinho FJ; Prinos P; Singh S; Donovan LK; Daniels C; Schramek D; Tyers M; Weiss S; Stein LD; Lupien M; Wouters BG; Garcia BA; Arrowsmith CH; Sorensen PH; Angers S; Jabado N; Dirks PB; Mack SC; Agnihotri S; Rich JN; Taylor MD
Cell; 2020 Jun; 181(6):1329-1345.e24. PubMed ID: 32445698
[TBL] [Abstract][Full Text] [Related]
10. Portrait of ependymoma recurrence in children: biomarkers of tumor progression identified by dual-color microarray-based gene expression analysis.
Peyre M; Commo F; Dantas-Barbosa C; Andreiuolo F; Puget S; Lacroix L; Drusch F; Scott V; Varlet P; Mauguen A; Dessen P; Lazar V; Vassal G; Grill J
PLoS One; 2010 Sep; 5(9):e12932. PubMed ID: 20885975
[TBL] [Abstract][Full Text] [Related]
11. DNA methylation-based classification of ependymomas in adulthood: implications for diagnosis and treatment.
Witt H; Gramatzki D; Hentschel B; Pajtler KW; Felsberg J; Schackert G; Löffler M; Capper D; Sahm F; Sill M; von Deimling A; Kool M; Herrlinger U; Westphal M; Pietsch T; Reifenberger G; Pfister SM; Tonn JC; Weller M;
Neuro Oncol; 2018 Nov; 20(12):1616-1624. PubMed ID: 30053291
[TBL] [Abstract][Full Text] [Related]
12. Supratentorial ependymoma in childhood: more than just RELA or YAP.
Zschernack V; Jünger ST; Mynarek M; Rutkowski S; Garre ML; Ebinger M; Neu M; Faber J; Erdlenbruch B; Claviez A; Bielack S; Brozou T; Frühwald MC; Dörner E; Dreschmann V; Stock A; Solymosi L; Hench J; Frank S; Vokuhl C; Waha A; Andreiuolo F; Pietsch T
Acta Neuropathol; 2021 Mar; 141(3):455-466. PubMed ID: 33481105
[TBL] [Abstract][Full Text] [Related]
13. Papillary Tumor of the Pineal Region: A Distinct Molecular Entity.
Heim S; Sill M; Jones DT; Vasiljevic A; Jouvet A; Fèvre-Montange M; Wesseling P; Beschorner R; Mittelbronn M; Kohlhof P; Hovestadt V; Johann P; Kool M; Pajtler KW; Korshunov A; Ruland V; Sperveslage J; Thomas C; Witt H; von Deimling A; Paulus W; Pfister SM; Capper D; Hasselblatt M
Brain Pathol; 2016 Mar; 26(2):199-205. PubMed ID: 26113311
[TBL] [Abstract][Full Text] [Related]
14. TERT promoter mutation and chromosome 6 loss define a high-risk subtype of ependymoma evolving from posterior fossa subependymoma.
Thomas C; Thierfelder F; Träger M; Soschinski P; Müther M; Edelmann D; Förster A; Geiler C; Kim HY; Filipski K; Harter PN; Schittenhelm J; Eckert F; Ntoulias G; May SA; Stummer W; Onken J; Vajkoczy P; Schüller U; Heppner FL; Capper D; Koch A; Kaul D; Paulus W; Hasselblatt M; Schweizer L
Acta Neuropathol; 2021 Jun; 141(6):959-970. PubMed ID: 33755803
[TBL] [Abstract][Full Text] [Related]
15. Candidate genes on chromosome 9q33-34 involved in the progression of childhood ependymomas.
Puget S; Grill J; Valent A; Bieche I; Dantas-Barbosa C; Kauffmann A; Dessen P; Lacroix L; Geoerger B; Job B; Dirven C; Varlet P; Peyre M; Dirks PB; Sainte-Rose C; Vassal G
J Clin Oncol; 2009 Apr; 27(11):1884-92. PubMed ID: 19289631
[TBL] [Abstract][Full Text] [Related]
16. Methylation of RASSF1A and TRAIL pathway-related genes is frequent in childhood intracranial ependymomas and benign choroid plexus papilloma.
Michalowski MB; de Fraipont F; Michelland S; Entz-Werle N; Grill J; Pasquier B; Favrot MC; Plantaz D
Cancer Genet Cytogenet; 2006 Apr; 166(1):74-81. PubMed ID: 16616114
[TBL] [Abstract][Full Text] [Related]
17. Preferential sites of metastatic relapse on MRI of initially localized ependymoma in children.
Rootman MS; Konen O; Fried I; Toledano H
Clin Imaging; 2017; 44():12-15. PubMed ID: 28395190
[TBL] [Abstract][Full Text] [Related]
18. Into Thin Air: Hypoxia Drives Metabolic and Epigenomic Deregulation of Lethal Pediatric Ependymoma.
Englinger B; Hack OA; Filbin MG
Dev Cell; 2020 Jul; 54(2):134-136. PubMed ID: 32693052
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic Alterations of Repeated Relapses in Patient-matched Childhood Ependymomas.
Zhao S; Li J; Zhang H; Qi L; Du Y; Kogiso M; Braun FK; Xiao S; Huang Y; Li J; Teo WY; Lindsay H; Baxter P; Su JMF; Adesina A; Laczik M; Genevini P; Veillard AC; Schvartzman S; Berguet G; Ding SR; Du L; Stephan C; Yang J; Davies PJA; Lu X; Chintagumpala M; Parsons DW; Perlaky L; Xia YF; Man TK; Huang Y; Sun D; Li XN
Nat Commun; 2022 Nov; 13(1):6689. PubMed ID: 36335125
[TBL] [Abstract][Full Text] [Related]
20. Multiple chromosomal monosomies are characteristic of giant cell ependymoma.
Dahlback HS; Brandal P; Krossnes BK; Fric R; Meling TR; Meza-Zepeda LA; Danielsen HE; Heim S
Hum Pathol; 2011 Dec; 42(12):2042-6. PubMed ID: 21683982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
